C&L: QLT taps Butchofsky as CEO

QLT has appointed Robert Butchofsky as president, CEO and as a director of the board.

Xenomics named company co-founder L. David Tomei, Ph.D., as its new CEO. 

BioScrip announced that CEO Henry F. Blissenbach will retire upon the expiration of his contract, effective June 30, 2006. BioScrip executive chairman, Richard H. Friedman will assume the role of interim CEO.

Gene Express has promoted Gerald J. Vardzel, Jr. to CEO.

David Patteson, president of the business area discovery chemistry at Biotage, has decided "to seek new challenges elsewhere." The new CEO of Biotage, Torben Jorgensen, will take over Patteson's responsibilities.

Eli Lilly's chief financial officer, Charles Golden, will retire from the company on April 30.

Alan Horgan has been named as Octagon Research Solutions' COO.

Schering-Plough named Tudor Panu, M.D. general manager, Romania.

Depomed named Bret Berner, Ph.D., vice president, product development, to the additional title of chief scientific officer.

Kosan Biosciences Incorporated has appointed Peter Licari, Ph.D. senior vice president, manufacturing and operations and Pieter Timmermans, Ph.D senior vice president, drug discovery and preclinical development.

EPIX Pharmaceuticals announced that Brenda Sousa and Philip Graham, Ph.D. have been promoted to vice president.

Cell Therapeutics named Dan Eramian, former vice president of communications at Biotechnology Industry Organization, as executive vice president of corporate communications.

Lifeline Biotechnologies announced that Dr. Kefah Mokbel has joined its medical advisory board.

Barrett Rollins, M.D., Ph.D. has joined the scientific advisory board of Merrimack Pharmaceuticals.

Tommy G. Thompson, former United States Secretary of Health and Human Services, has joined the board of directors of PURE Bioscience.

Acrongenomics has appointed Dr. Manos Topoglidis to its board of directors and scientific advisory board as chief technology officer.

Dynavax Technologies announced that Arnold L. Oronsky, PhD, has been elected chairman of Dynavax's board of directors.

Genzyme has elected Richard F. Syron to the company's board of directors.

Teranode Corporation has elected Paul Bleicher, MD, PhD to its board of directors.

Isotechnika has appointed Franklin M. Berger, CFA, to its board of directors. Avalon Pharmaceuticals has elected William H. Washecka to its board of directors.